Insight Molecular Diagnostics (IMDX) Debt Ratio (2015 - 2026)

Insight Molecular Diagnostics has disclosed Debt Ratio across 12 years of filings, most recently posting 0.0 for Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.0, down 45.17% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0 (down 45.17% YoY), and the FY2025 annual result was 0.02, up 155.68% from the prior year.
• Debt Ratio came in at 0.0 for Q1 2026 at Insight Molecular Diagnostics, down from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.03 in Q4 2023 to a low of 0.0 in Q3 2022.
• The 5-year median for Debt Ratio is 0.0 (2022), against an average of 0.01.
• Across the five-year window, Debt Ratio slumped 94.86% in 2022 and soared 2737.24% in 2023, its largest moves.
• Insight Molecular Diagnostics' Debt Ratio stood at 0.0 in 2022, then jumped by 2737.24% to 0.03 in 2023, then plunged by 78.97% to 0.01 in 2024, then soared by 155.68% to 0.02 in 2025, then plunged by 76.33% to 0.0 in 2026.
• The last three Debt Ratio figures came in at 0.0 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.